Amputation After Endovascular Therapy With and Without Intravascular Ultrasound Guidance: A Nationwide Propensity Score-Matched Study

被引:8
|
作者
Setogawa, Nao [1 ,2 ]
Ohbe, Hiroyuki [1 ]
Matsui, Hiroki [1 ]
Yasunaga, Hideo [1 ]
机构
[1] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan
[2] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan
关键词
endovascular procedures; interventional ultrasonography; peripheral arterial disease; propensity score; PERIPHERAL ARTERY-DISEASE; OUTCOMES; IMPACT; IVUS;
D O I
10.1161/CIRCINTERVENTIONS.122.012451
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Intravascular ultrasound (IVUS) provides precise intravascular information during endovascular therapy (EVT). However, the clinical efficacy of IVUS in patients who undergo EVT remains unknown. The present study aimed to determine whether the use of IVUS-guided EVT is associated with better clinical outcomes in a real-world setting.Methods: Using the Japanese Diagnosis Procedure Combination administrative inpatient database from April 2014 to March 2019, we identified patients diagnosed with atherosclerosis of arteries of extremities and underwent EVT (percutaneous endovascular transluminal angioplasty and thrombectomy for extremities or percutaneous endovascular removal). Propensity score matching analysis was performed to compare outcomes between the patients who underwent IVUS on the same day as the first EVT intervention (IVUS group) and the others (non-IVUS group). The primary outcome was major and minor amputation for extremities within 12 months of the first EVT procedure. Secondary outcomes were bypass surgery, stent grafting, reintervention, all-cause death, readmission, and total hospitalization costs within 12 months of the first EVT procedure.Results: Among 85 649 eligible patients, 50 925 (59.5%) were IVUS group. After propensity score matching, the IVUS group had significantly lower incidence of 12-month amputation compared with the non-IVUS group (6.9% in the IVUS group versus 9.3% in the non-IVUS group; hazard ratio, 0.80 [95% CI, 0.72-0.89]). Compared with the non-IVUS group, the IVUS group showed a lower risk of bypass surgery and stent grafting and decreased total hospitalization costs, while a higher risk of reintervention and readmission. No significant differences in all-cause death were found between the 2 groups.Conclusions: In this retrospective study, IVUS-guided EVT was associated with a lower amputation risk than non-IVUS-guided EVT. Our findings should be interpreted carefully because of the limitations of an observational study using administrative data. Further studies are warranted to confirm whether IVUS-guided EVT leads to decreased amputations.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
  • [1] Pancreatic surgery with or without drainage: propensity score-matched study
    Nickel, Felix
    Lang, Franziska
    Kowalewski, Karl-Friedrich
    Haney, Caelan Max
    Menrath, Marc
    Berchtold, Christoph
    Hoffmann, Katrin
    Loos, Martin
    Mehrabi, Arianeb
    Probst, Pascal
    Schmidt, Thomas
    Schneider, Martin
    Diener, Markus K.
    Strobel, Oliver
    Muller-Stich, Beat P.
    Hackert, Thilo
    BRITISH JOURNAL OF SURGERY, 2022, 109 (08) : 739 - 745
  • [2] Gender disparity in esophageal cancer - a nationwide propensity score-matched study
    Chou, Y.
    Lee, Y.
    Tseng, H.
    Chiou, J.
    Huang, J.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S554 - S554
  • [3] Risk of developing hypertension after hormone therapy for prostate cancer: a nationwide propensity score-matched longitudinal cohort study
    Yi-Hsuan Wu
    Jhen-Hao Jhan
    Hung-Lung Ke
    Shih-I Tseng
    Yu-Han Chang
    Hsin-Chih Yeh
    Ching-Chia Li
    Yung-Chin Lee
    International Journal of Clinical Pharmacy, 2020, 42 : 1433 - 1439
  • [4] Risk of developing hypertension after hormone therapy for prostate cancer: a nationwide propensity score-matched longitudinal cohort study
    Wu, Yi-Hsuan
    Jhan, Jhen-Hao
    Ke, Hung-Lung
    Tseng, Shih-, I
    Chang, Yu-Han
    Yeh, Hsin-Chih
    Li, Ching-Chia
    Lee, Yung-Chin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (06) : 1433 - 1439
  • [5] Risk of revision in UKA versus HTO: a nationwide propensity score-matched study
    Jae-Doo Yoo
    Min-Hwan Huh
    Young-Soo Shin
    Archives of Orthopaedic and Trauma Surgery, 2023, 143 : 3457 - 3469
  • [6] Risk of revision in UKA versus HTO: a nationwide propensity score-matched study
    Yoo, Jae-Doo
    Huh, Min-Hwan
    Shin, Young-Soo
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2023, 143 (06) : 3457 - 3469
  • [7] Corticosteroid Therapy for Patients With Severe Fever With Thrombocytopenia Syndrome: A Nationwide Propensity Score-Matched Study in Japan
    Shuto, Hisayuki
    Komiya, Kosaku
    Usagawa, Yuko
    Yamasue, Mari
    Fushimi, Kiyohide
    Hiramatsu, Kazufumi
    Kadota, Jun-ichi
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (08):
  • [8] Survival of patients with colorectal liver metastases treated with and without preoperative chemotherapy: Nationwide propensity score-matched study
    de Graaff, Michelle. R.
    Klaase, Joost M.
    van Dam, Ronald M.
    Kuhlmann, Koert F. D.
    Kazemier, Geert
    Swijnenburg, Rutger-Jan
    Elfrink, Arthur K. E.
    Verhoef, Cees
    Mieog, J. Sven
    van den Boezem, Peter B.
    Gobardhan, Paul
    Rijken, Arjen M.
    Lips, Daan J.
    Leclercq, Wouter G. K.
    Marsman, Hendrik A.
    van Duijvendijk, Peter
    van der Hoeven, Joost A. B.
    Vermas, Marteb
    den Dulk, Marcel
    Grunhagen, Dirk J.
    Kok, Niels F. M.
    EJSO, 2023, 49 (09):
  • [9] Association of Depression and Cervical Spondylosis: A Nationwide Retrospective Propensity Score-Matched Cohort Study
    Lin, Shih-Yi
    Sung, Fung-Chang
    Lin, Cheng-Li
    Chou, Li-Wei
    Hsu, Chung-Y
    Kao, Chia-Hung
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (11)
  • [10] Comparison of feasibility and effectiveness of tunneled dialysis catheter placement with or without DSA guidance: a propensity score-matched cohort study
    Shang, Yiwei
    Pan, Shujun
    Jin, Chen
    Zheng, Danna
    Xu, Xiujun
    Zhu, Bin
    Zhao, Li
    Jin, Juan
    He, Qiang
    Shen, Xiaogang
    RENAL FAILURE, 2024, 46 (02)